Come and join us on 6 July and hear 4 AIM CEO’s speak. Brad George, Orosur CEO updates us on Colombia’s Tier-1 gold mine potential, Cliff Gross, CEO at Tekcapital explains how investors benefit from a special dividend. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,488.00
Bid: 8,487.00
Ask: 8,489.00
Change: 73.00 (0.87%)
Spread: 2.00 (0.02%)
Open: 8,380.00
High: 8,494.00
Low: 8,354.00
Yest. Close: 8,415.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Wednesday broker round-up

Wed, 12th May 2021 13:55

(Sharecast News) - Air Partner: Canaccord reiterates buy with a target price of 100p.



Ashtead Group: JP Morgan reiterates overweight with a target price of 5,050p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

The Hut Group: Barclays reiterates overweight with a target price of 890p.

FDM Group: Barclays reiterates overweight with a target price of 1,060p.

Chesnara: Peel Hunt reiterates hold with a target price of 280p.

FirstGroup: Liberum reiterates buy with a target price of 105p.

Mears Group: Liberum reiterates hold with a target price of 190p.

Vesuvius: Numis reiterates buy with a target price of 675p.

Next: Credit Suisse reiterates underperform with a target price of 7,150p.

National Grid: Credit Suisse reiterates outperform with a target price of 1,020p.

More News

UPDATE 1-South Africa to ramp up COVID-19 vaccinations as opposition protests

(Updates with EFF march)JOHANNESBURG, June 25 (Reuters) - Several thousand supporters of a leftist party demonstrated outside the offices of South Africa's health regulator on Friday to protest against the slow coronavirus vaccine roll-out in Afr...

Today 14:08

UPDATE 1-Denmark continues exclusion of J&J, AstraZeneca COVID-19 vaccines

(Adds confirmation, health agency comment, includes AstraZeneca shot)COPENHAGEN, June 25 (Reuters) - Danish health authorities said on Friday that COVID-19 vaccines from AstraZeneca and Johnson & Johnson would remain excluded from Denmark's vacci...

Today 12:12

UPDATE 2-Denmark continues exclusion of J&J, AstraZeneca COVID-19 vaccines

(Adds details, background)By Nikolaj SkydsgaardCOPENHAGEN, June 25 (Reuters) - Health authorities in Denmark said on Friday that COVID-19 vaccines from AstraZeneca and Johnson & Johnson would remain excluded from the country's vaccine roll-out fol...

Today 12:12

Denmark continues to exclude J&J COVID-19 vaccine from national roll-out - TV 2

COPENHAGEN, June 25 (Reuters) - Denmark will continue to exclude Johnson & Johnson's COVID-19 vaccine from its national vaccine roll-out, broadcaster TV 2 reported on Friday without specifying its sources.It did say whether AstraZeneca's shot woul...

Today 11:56

South Africa aims to more than double daily COVID-19 vaccinations over next month

JOHANNESBURG, June 25 (Reuters) - South Africa aims to more than double the rate of daily COVID-19 vaccinations over the next month to more than 200,000 as more Pfizer and Johnson & Johnson shots arrive, health officials said on Friday.The countr...

Today 11:10

Swiss health ministry data shows vaccinated people seldom hit by COVID-19

By John MillerZURICH, June 24 (Reuters) - Switzerland's move to allow large public events with 10,000-plus people from Saturday comes as government data appears to show vaccines are helping control new infections that are mostly hitting people who...

24 Jun 21 17:36

Oxford researchers say they developed blood test predictor of vaccine efficacy

By Ludwig BurgerFRANKFURT, June 24 (Reuters) - Researchers at Oxford University said on Thursday they have developed a method to predict the efficacy of new COVID-19 vaccines based on a blood test, potentially offering a short-cut around massive c...

24 Jun 21 16:01

UPDATE 2-FTSE 100 rises on dovish BoE; miners, pharma stocks lead gains

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* BoE maintains loose monetary policy* AstraZeneca, Anglo American top boosts to FTSE 100* Carnival falls after $2 billion quarterly loss* FT...

24 Jun 21 09:58

AstraZeneca, MSD prostate cancer drug gets China green light

(Sharecast News) - AstraZeneca and MSD's Lynparza prostate cancer drug has been granted conditional approval in China after a successful phase three trial, the companies said on Thursday.

24 Jun 21 07:34

Seychelles looking to diversity economy beyond tourism post-COVID - minister

By Omar MohammedNAIROBI, June 23 (Reuters) - Seychelles said on Wednesday it is looking to diversify its economy beyond its mainstay of tourism into areas such as fisheries after visitor numbers were battered by restrictions to arrest the spread o...

23 Jun 21 13:37

Wednesday broker round-up

(Sharecast News) - Hunting: JP Morgan upgrades overweight with a target price of 290p.

23 Jun 21 13:04

UPDATE 1-GSK pledges sales boost after split from consumer arm

(Adds details, background)June 23 (Reuters) - New GSK, the pharmaceuticals business being separated from its consumer health operations, pledged to increase sales by more than 5% a year to 2026, the group said on Wednesday, as it published details...

23 Jun 21 11:35

UPDATE 2-GSK's drugs arm to get $11 bln windfall from consumer spin-off

* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds CEO comment, detail, background)By Ludwig Burger and Pushkala AripakaJun...

23 Jun 21 11:35

UPDATE 3-GSK's drugs arm to get $11 bln booster from consumer spin-off

* GSK consumer arm to be demerged in middle of 2022* Drugs business to get 8 bln stg dividend from consumer arm* Lower debt ratio, dividend to boost finances of drugs arm (Adds details on dividend, debt, Pfizer comment, updates shares)By Ludwig Bur...

23 Jun 21 11:35

GSK sets out plans for listing of consumer products venture

June 23 (Reuters) - Britain's GSK on Wednesday unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next year, as the pharmaceutical giant sharpens its focus on prescription med...

23 Jun 21 11:10

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.